drugset / Trial / NCT00830258
Pravastatin Sodium 80 mg Tablets Under Fasting Conditions
RandomizedCrossoverOpen-labelOther
Summary
The objective of this study is to evaluate the comparative bioavailability between pravastatin sodium 80 mg tablets (Distributed by Teva Pharmaceuticals, USA) and Pravachol® 80 mg tablets (Bristol Myers Squibb, USA), after a single-dose in healthy subjects under fasting conditions.
Timeline
- Start
- 2005-04
- Primary completion
- 2005-04
- Completion
- 2005-04
Outcome
Met primary endpoint
registry Geometric Test/Ref Ratio x 100 105.76 (90% CI 98.17 to 113.93) NCT00830258 ↗
registry Geometric Test/Ref Ratio x 100 110.45 (90% CI 104.31 to 116.96) NCT00830258 ↗
registry Geometric Test/Ref Ratio x 100 110.61 (90% CI 104.39 to 117.20) NCT00830258 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pravastatin | Small molecule | 80 mg | — |
Indications
No indication recorded.